The study will take part in two phases. Phase I women will not receive the risk prediction but will be invited to complete three questionnaires relating to anxiety and depressive symptoms. Phase II women will receive the risk prediction (intervention) and will also be invited to complete the same three questionnaires as the women in Phase I. The responses will then be analysed once recruitment is complete.